Clinical Trials Directory

Trials / Suspended

SuspendedNCT07140965

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

Status
Suspended
Phase
Study type
Observational
Enrollment
175 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To learn if Pegulicianine Fluorescence-Guided Surgery (pFGS), which is part of the Lumicell Direct Visualization System, and Digital Breast Tomosynthesis (DBT) can improve the identification of tumor margins during a partial mastectomy and decrease the need for a second surgery.

Detailed description

Primary Objectives: -To determine if surgeon interpretation of pFGS and DBT has a higher specificity compared to SEP, resulting in fewer excisions of additional tissue unnecessarily Secondary Objectives: * To determine if surgeon evaluation of segmental mastectomy margins using pFGS and DBT is associated with better patient- and physician-reported cosmesis * To determine if surgeon interpretation of pFGS and DBT results in a lower rate of positive margins after BCS compared to SEP * To determine if surgeon interpretation of pFGS and DBT has a shorter operative time compared to SEP. * To determine if surgeon interpretation of pFGS and DBT results in less delays in receipt of adjuvant treatment and the reduction of targeted volume of radiation therapy or omission of radiation altogether

Conditions

Interventions

TypeNameDescription
PROCEDUREPegulicianine Fluorescence-Guided SurgeryGiven by Surgery
PROCEDUREDigital Breast TomosynthesisGiven by Procedure
PROCEDUREBreast Conserving TherapyGiven by Procedure

Timeline

Start date
2025-10-09
Primary completion
2027-09-30
Completion
2029-09-30
First posted
2025-08-26
Last updated
2026-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07140965. Inclusion in this directory is not an endorsement.